GVG en es it fr

GVG Brand names, GVG Analogs

GVG Brand Names Mixture

  • No information avaliable

GVG Chemical_Formula


GVG RX_link

No information avaliable

GVG fda sheet

GVG msds (material safety sheet)

GVG Synthesis Reference

No information avaliable

GVG Molecular Weight

129.157 g/mol

GVG Melting Point

No information avaliable

GVG H2O Solubility

55.1 mg/mL

GVG State




GVG Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

GVG Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

GVG Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

GVG Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

GVG side effects and Toxicity

No information avaliable

GVG Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

GVG Organisms Affected

Humans and other mammals